| Literature DB >> 35164373 |
Chen Song1,2,3, Sijia Li1,2,3, Fangyuan Duan1,2,3, Mengyao Liu1,2,3, Shan Shan1,2,3, Ting Ju1,2,3, Yingchun Zhang1,2,3, Weihong Lu1,2,3.
Abstract
Acanthopanax senticosus (AS) is a medicinal and food homologous plant with many biological activities. In this research, we generated a brain injury model by 60Co -γ ray radiation at 4 Gy, and gavaged adult mice with the extract with AS, Acanthopanax senticocus polysaccharides (ASPS), flavones, syringin and eleutheroside E (EE) to explore the therapeutic effect and metabolic characteristics of AS on the brain injury. Behavioral tests and pathological experiments showed that the AS prevented the irradiated mice from learning and memory ability impairment and protected the neurons of irradiated mice. Meanwhile, the functional components of AS increased the antioxidant activity of irradiated mice. Furthermore, we found the changes of neurotransmitters, especially in the EE and syringin groups. Finally, distribution and pharmacokinetic analysis of AS showed that the functional components, especially EE, could exert their therapeutic effects in brain of irradiated mice. This lays a theoretical foundation for the further research on the treatment of radiation-induced brain injury by AS.Entities:
Keywords: brain injury; functional components of Acanthopanax senticosus; neurotransmitters; pharmacokinetic; radiation
Mesh:
Substances:
Year: 2022 PMID: 35164373 PMCID: PMC8839712 DOI: 10.3390/molecules27031106
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The completion of water maze in each group of mice. (A) The number of snags of each group; (B) the platform arrival time; (C) the location score; (D) the sugar partiality of each group (n = 8 per group, * p < 0.5, ** p < 0.01, significant differences between the groups were tested by one-way analysis of variance).
Figure 2Histopathological sections of hippocampus in different groups of mice: (A) Control group; (B) Model group; (C) AS group; (D) ASPS group; (E) EE group; (F) Flavones group; (G) Syringin group; (H) Venlafaxine group. (Three mice were used in this analysis and the representative pictures were shown, scale bar = 50 um).
Figure 3The level of antioxidant enzyme activity in brain of each group. (A) The level of SOD in the brains of mice; (B) the level of CAT in the brain of mice; (C) the level of MDA in the brain of mice; (D) The level of GSH in the brain of mice. (* p < 0.05, ** p < 0.01, n = 5, significant differences between the groups were tested by one-way analysis of variance.)
Figure 4The level of neurotransmitters in brain of each group. (* p < 0.05, ** p < 0.01, n = 5). (A) The level of NE in the brains of mice; (B) the level of 5-HT in the brains of mice; (C) the level of MAO in the brain of mice; (D) the level of ACH in brain of mice. (* p < 0.05, ** p < 0.01, n = 5, significant differences between the groups were tested by one-way analysis of variance.)
The content of functional components of AS in tissues (ug/mL).
| Polysaccharide | Flavones | Syringin | EE | |
|---|---|---|---|---|
| Liver | 1.88 ± 0.06 a | 10.62 ± 0.05 d | 0.64 ± 0.01 a | 1.06 ± 0.01 a |
| Thymus | 0.62 ± 0.04 c | 6.84 ± 0.05 e | 0.14 ± 0.00 b | 0.08 ± 0.01 b |
| Spleen | 0.64 ± 0.01 b | 12.07 ± 0.02 c | 0.36 ± 0.01 b | 1.42 ± 0.03 a |
| Kidney | 0.72 ± 0.03 bc | 13.77 ± 0.03 b | 0.72 ± 0.03 a | 1.02 ± 0.01 a |
| Testis | 0.52 ± 0.03 c | 6.31 ± 0.01 f | 0.02 ± 0.001 c | 0.12 ± 0.01 b |
| Heart | 0.91 ± 0.04 c | 15.07 ± 0.10 a | 0.06 ± 0.02 c | 0.02 ± 0.01 b |
| Brain | 0.07 ± 0.25 d | 12.07 ± 0.09 c | 0.04 ± 0.01 d | 0.05 ± 0.09 b |
Vertical comparison of different letters in the upper right corner means significant difference (p < 0.05, significant differences between the groups were tested by one-way analysis of variance).
Figure 5Pharmacokinetic curve of functional components of Acanthopanax senticocus in brain tissue. (A) Pharmacokinetic curve of ASPS; (B) pharmacokinetic curve of EE; (C) pharmacokinetic curve of flavones; (D) pharmacokinetic curve of syingin.
Pharmacokinetics parameters of AS component in brain.
| Polysaccharide | Flavones | Syringin | EE | |
|---|---|---|---|---|
| t1/2 (h) | 16.11 ± 0.99 b | 7.92 ± 0.34 c | 38.58 ± 0.84 a | 38.35 ± 0.34 a |
| Tmax (h) | 2.00 ± 0.00 a | 2.00 ± 0.00 a | 2.00 ± 0.00 a | 2.00 ± 0.00 a |
| CL (mg mL/μgh) | 0.12 ± 0.03 b | 0.22 ± 0.06 b | 0.10 ± 0.08 b | 0.91 ± 0.06 a |
| Cmax (μg/mL) | 38.12 ± 0.08 a | 3.31 ± 0.03 c | 1.26 ± 0.09 d | 11.43 ± 0.03 b |
| AUC(0-inf) (μgh/mL) | 16.70 ± 1.84 b | 17.65 ± 1.01 c | 0.23 ± 0.11 d | 0.22 ± 0.05 a |
| F (%) | 0.04 ± 0.01 b | 0.10 ± 0.05 c | 0.08 ± 0.03 d | 0.15 ± 0.02 a |
| MRT (h) | 21.87 ± 1.95 b | 84.28 ± 0.44 a | 80.28 ± 0.14 a | 53.05 ± 0.44 c |
| V (mg mL/μg) | 0.31 ± 0.07 c | 1.15 ± 0.14 b | 1.48 ± 0.54 b | 3.71 ± 0.14 a |
Vertical comparison of different letters means significant difference (p < 0.05, significant differences between the groups were tested by one-way analysis of variance).